EMMAUS LIFE SCIENCES, INC. Debt Securities, Available-for-sale, Unrealized Gain (Loss)
EMMAUS LIFE SCIENCES, INC. (EMMA) reported Debt Securities, Available-for-sale, Unrealized Gain (Loss) of $117.00 thousand for the 3-month period ending 2022-03-31, per its 10-Q filed 2023-05-15.
Discontinued › Income Statement › Other Income
us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss · last filed 2023-05-15
- EMMAUS LIFE SCIENCES, INC. debt securities, available-for-sale, unrealized gain (loss) for the quarter ending 2022-03-31 was $117.00K, a 515.79% increase year-over-year.
- EMMAUS LIFE SCIENCES, INC. debt securities, available-for-sale, unrealized gain (loss) for the quarter ending 2021-06-30 was $182.00K.
- EMMAUS LIFE SCIENCES, INC. debt securities, available-for-sale, unrealized gain (loss) for the quarter ending 2021-03-31 was $19.00K.
- EMMAUS LIFE SCIENCES, INC. debt securities, available-for-sale, unrealized gain (loss) for fiscal 2020 was $427.00K.
| Period end | Debt Securities, Available-for-sale, Unrealized Gain (Loss) 3 month | Debt Securities, Available-for-sale, Unrealized Gain (Loss) 6 month | Debt Securities, Available-for-sale, Unrealized Gain (Loss) 12 month |
|---|---|---|---|
| 2022-03-31 | $117.00K 10-Q · filed 2023-05-15 | ||
| 2021-06-30 | $182.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $201.00K 10-Q · filed 2022-08-15 | |
| 2021-03-31 | $19.00K 10-Q · filed 2022-05-13 | ||
| 2020-12-31 | $427.00K 10-K · filed 2022-03-31 |